Unexpected distribution of cKIT and BRAF mutations among Southern Italian patients with sinonasal melanoma

Dermatology

Volumn 226, Issue 3, 2013, Pages 279-284

  Colombino, Maria ^a   Lissia, Amelia ^b   Franco, Renato ^d   Botti, Gerardo ^d   Ascierto, Paolo A ^d   Manca, Antonella ^a   Sini, Maria Cristina ^a   Pisano, Marina ^a   Paliogiannis, Panagiotis ^c   Tanda, Francesco ^c   Palmieri, Giuseppe ^a   Cossu, Antonio ^b  

^a Institute of High Performance Computing and Networking CNR   (United States)

^b Azienda Ospedaliero Universitaria   (Italy)

^c UNIVERSITY OF SASSARI   (Italy)

^d NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

BRAF; cKIT; Melanoma; Mutation analysis; Sinonasal

Indexed keywords

B RAF KINASE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE MUTATION; GENE SEQUENCE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; ITALIAN (CITIZEN); MALE; MELANOMA; ONCOGENE C KIT; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SINONASAL MELANOMA;

EID: 84927693276     PISSN: 10188665     EISSN: 14219832     Source Type: Journal    
DOI: 10.1159/000350683     Document Type: Article

References (24)

1. Russo AE, Torrisi E, Bevelacqua Y, Perrotta R, Libra M, McCubrey JA, Spandidos DA, Stivala F, Malaponte G: Melanoma: molecular pathogenesis and emerging target therapies. Int J Oncol 2009; 34: 1481-1489.
2. Curado MP, Edwards B, Shin HR, Storm H, Ferlay J, Heanue M, Boyle P (eds): Cancer Incidence in Five Continents, vol IX. Lyon, IARC, 2007.
3. Thompson JF, Scolyer RA, Kefford RF: Cutaneous melanoma. Lancet 2005; 365: 687-701.
4. Lipsker D, Engel F, Cribier B, Velten M, Hedelin G: Trends in melanoma epidemiology suggest three different types of melanoma. Br J Dermatol 2007: 157: 338-343.
5. Postow MA, Hamid O, Carvajal RD: Mucosal melanoma: pathogenesis, clinical behavior, and management. Curr Oncol Rep 2012; 14: 441-448.
6. Cho E, Rosner BA, Feskanich D, Colditz GA: Risk factors and individual probabilities of melanoma for whites. J Clin Oncol 2005; 23: 2669-2675.
7. Curtin JA, Fridlyand J, Kageshita T, Patel HN, Busam KJ, Kutzner H, Cho KH, Aiba S, Bröcker EB, LeBoit PE, Pinkel D, Bastian BC: Distinct sets of genetic alterations in melanoma. N Engl J Med 2005; 353: 2135-2147.
8. Curtin JA, Busam K, Pinkel D, Bastian BC: Somatic activation of KIT in distinct subtypes of melanoma. J Clin Oncol 2006; 24: 4340-4346.
9. Antonescu CR, Busam KJ, Francone TD, Wong GC, Guo T, Agaram NP, Besmer P, Jungbluth A, Gimbel M, Chen CT, Veach D, Clarkson BD, Paty PB, Weiser MR: L576P KIT mutation in anal melanomas correlates with KIT protein expression and is sensitive to specific kinase inhibition. Int J Cancer 2007; 121: 257-264.
10. Beadling C, Jacobson-Dunlop E, Hodi FS, Le C, Warrick A, Patterson J, Town A, Harlow A, Cruz F 3rd, Azar S, Rubin BP, Muller S, West R, Heinrich MC, Corless CL: KIT gene mutations and copy number in melanoma subtypes. Clin Cancer Res 2008; 14: 6821-6828.
11. Schoenewolf NL, Bull C, Belloni B, Holzmann D, Tonolla S, Lang R, Mihic-Probst D, Andres C, Dummer R: Sinonasal, genital and acrolentiginous melanomas show distinct characteristics of KIT expression and mutations. Eur J Cancer 2012; 48: 1842-1852.
12. Kingdom TT, Kaplan MJ: Mucosal melanoma of the nasal cavity and paranasal sinuses. Head Neck 1995; 17: 184-189.
13. Clifton N, Harrison L, Bradley PJ, Jones NS: Malignant melanoma of nasal cavity and paranasal sinuses: report of 24 patients and literature review. J Laryngol Otol 2011; 125: 479-485.
14. Minor DR, Kashani-Sabet M, Garrido M, O'Day SJ, Hamid O, Bastian BC: Sunitinib therapy for melanoma patients with KIT mutations. Clin Cancer Res 2012; 18: 1457-1463.
15. Palmieri G, Rozzo C, Gentilcore G, Ascierto PA: Melanoma pathophysiology and drug targets; in Marincola FM, Ascierto PA, Kirkwood JM (eds): Emerging Therapeutics for Melanoma. London, Future Medicine LTD, 2012, pp 6-17.
16. Ashida A, Takata M, Murata H, Kido K, Saida T: Pathological activation of KIT in metastatic tumors of acral and mucosal melanomas. Int J Cancer 2009; 124: 862-868.
17. Casula M, Muggiano A, Cossu A, Budroni M, Caracò C, Ascierto PA, Pagani E, Stanganelli I, Canzanella S, Sini M, Palomba G, Palmieri G, Italian Melanoma Intergroup (IMI): Role of key-regulator genes in melanoma susceptibility and pathogenesis among patients from South Italy. BMC Cancer 2009; 9: 352.
18. Colombino M, Capone M, Lissia A, Cossu A, Rubino C, De Giorgi V, Massi D, Fonsatti E, Staibano S, Nappi O, Pagani E, Casula M, Manca A, Sini M, Franco R, Botti G, Caracò C, Mozzillo N, Ascierto PA, Palmieri G: BRAF/NRAS mutation frequencies among primary tumors and metastases in patients with melanoma. J Clin Oncol 2012; 30: 2522-2529.
19. Satzger I, Schaefer T, Kuettler U, Broecker V, Voelker B, Ostertag H: Analysis of c-KIT expression and KIT gene mutation in human mucosal melanomas. Br J Cancer 2008; 99: 2065-2069.
20. Omholt K, Grafström E, Kanter-Lewensohn L, Hansson J, Ragnarsson-Olding BK: KIT pathway alterations in mucosal melanomas of the vulva and other sites. Clin Cancer Res 2011; 17: 3933-3942.
21. Takata M, Murata H, Saida T: Molecular pathogenesis of malignant melanoma: a different perspective from the studies of melanocytic nevus and acral melanoma. Pigment Cell Melanoma Res 2010; 23: 64-67.
22. Yun J, Lee J, Jang J, Lee EJ, Jang KT, Kim JH, Kim KM: KIT amplification and gene mutations in acral/mucosal melanoma in Korea. APMIS 2011; 119: 330-335.
23. Edwards RH, Ward MR, Wu H, Medina CA, Brose MS, Volpe P: Absence of BRAF mutations in UV-protected mucosal melanomas. J Med Genet 2004; 41: 270-272.
24. Rivera RS, Nagatsuka H, Gunduz M, Cengiz B, Gunduz E, Siar CH: C-kit protein expression correlated with activating mutations in KIT gene in oral mucosal melanoma. Virchows Arch 2008; 452: 27-32.